# Phase 1 Dosing Study of BAX 513 in Healthy Volunteers

> **NCT01063101** · PHASE1 · COMPLETED · sponsor: **Baxalta now part of Shire** · enrollment: 30 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **OTHER:** Fucoidan (extract of Laminaria japonica)
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01063101
- **Lead sponsor:** Baxalta now part of Shire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-01-29
- **Primary completion:** 2010-07-22
- **Final completion:** 2010-08-01
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01063101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01063101, "Phase 1 Dosing Study of BAX 513 in Healthy Volunteers". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01063101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*